Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotics vs. Surgery in Acute Appendicitis (ASAA)
NCT01421901Phase 4Unknown
- Sponsor
- Papa Giovanni XXIII Hospital
- Start
- Aug 2011
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ertapenem in acute appendicitis (2 arms), sponsored by Papa Giovanni XXIII Hospital. Primary endpoint: Rate of patients free of symptoms at 2 weeks. Status: unknown.
02
Drugs
ertapenem
03
Conditions
acute appendicitis
Beyond the preview
Go deeper on NCT01421901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01421901.